[508] IN HEPATITIS B PATIENTS TREATED WITH EITHER ADEFOVIR OR TELBIVUDINE, MAXIMAL EARLY HBV SUPPRESSION AT 24 WEEKS PREDICTS OPTIMAL ONE-YEAR EFFICACY

✍ Scribed by P. Marcellin; H.L.Y. Chan; C.-L. Lai; M. Clio; I. Heathcote; Y.-M. Moon; Y.-C. Chao; R. Myers; G. Harb; N.A. Brown

• Book ID: 117375601
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 129 KB
• Volume: 46
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(07)62106-0